Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: Impact on women's choices
- PMID: 35278232
- DOI: 10.1002/pd.6131
Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: Impact on women's choices
Abstract
Objective: To evaluate the implementation of non-invasive prenatal testing (NIPT) on pregnant women's choices in a national NHS antenatal screening programme for Down's syndrome, Edwards' syndrome and Patau's syndrome.
Method: An observational study of all pregnant women with a singleton pregnancy and higher chance (≤1:150) combined or quadruple screening result from 30 April 2018 to 25 September 2020 in Wales, UK. Pregnant women's journey through the pathway was determined including uptake of NIPT, performance of NIPT in a non-research setting and invasive procedures performed.
Results: Of the 1273 women with a higher chance initial screening, 1073 (84%) chose NIPT contingent test, 174 (14%) no further testing and 26 (2%) invasive procedure. There were 1001 (93%) low chance NIPT results; 11 (1%) failed results and 61 (6%) high chance results. Average annual incidence of 27 invasive procedures undertaken compared to 229 pre-NIPT implementation, a nearly ninefold reduction. Down's syndrome annual live birth rate remained unchanged across the implementation period.
Discussion: This study demonstrates that NIPT contingent screening was highly acceptable to women with a resulting reduction in invasive procedures performed.
Conclusion: The high uptake of NIPT in NHS antenatal screening pathway conditions should inform planning for other national screening programmes.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.PLoS One. 2024 May 16;19(5):e0298643. doi: 10.1371/journal.pone.0298643. eCollection 2024. PLoS One. 2024. PMID: 38753891 Free PMC article.
-
Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.BMJ. 2016 Jul 4;354:i3426. doi: 10.1136/bmj.i3426. BMJ. 2016. PMID: 27378786 Free PMC article.
-
Women's choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England.Arch Dis Child. 2020 Jan;105(1):47-52. doi: 10.1136/archdischild-2019-317031. Epub 2019 Jun 26. Arch Dis Child. 2020. PMID: 31243005
-
Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.BMC Pregnancy Childbirth. 2014 Jul 16;14:229. doi: 10.1186/1471-2393-14-229. BMC Pregnancy Childbirth. 2014. PMID: 25027965 Free PMC article.
-
Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.BMC Pregnancy Childbirth. 2019 Jan 14;19(1):27. doi: 10.1186/s12884-018-2168-4. BMC Pregnancy Childbirth. 2019. PMID: 30642270 Free PMC article.
Cited by
-
The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.PLoS One. 2024 May 16;19(5):e0298643. doi: 10.1371/journal.pone.0298643. eCollection 2024. PLoS One. 2024. PMID: 38753891 Free PMC article.
-
Improved contingent screening strategy increased trisomy 21 detection rate in the second trimester.Arch Gynecol Obstet. 2025 Apr;311(4):1029-1037. doi: 10.1007/s00404-024-07743-4. Epub 2024 Sep 21. Arch Gynecol Obstet. 2025. PMID: 39305319 Free PMC article.
-
Clinical strategy study on prenatal screening and diagnostic model for Down syndrome.Sci Rep. 2024 Sep 27;14(1):22269. doi: 10.1038/s41598-024-73183-4. Sci Rep. 2024. PMID: 39333230 Free PMC article.
References
REFERENCES
-
- Public Health Wales. Antenatal Screening Wales Policy, Standards and Protocols. Version 2b. Public Health Wales NHS Trust; 2019.
-
- Chitty, LS, Wright, D, Hill, M, et al. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units. BMJ. 2016;354:i3426.
-
- Lewis C, Hill M, Silcock C, Daley R, Chitty L. Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users’ views and likely uptake. BJOG. 2014;121(5):582-594.
-
- Royal College of Obstetricians and Gynaecologists. Amniocentesis and Chorionic Villus Sampling: Green-top Guideline No. 8; 2021. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg8/
-
- Lewis C, Silcock C, Chitty LS. Non-invasive prenatal testing for Down's syndrome: pregnant women's views and likely uptake. Public Health Genomics. 2013;16:223-232.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous